Life Insurance After a Cancer Diagnosis: What to Expect in Canada

A cancer diagnosis changes a lot, and for many people one of the questions that surfaces once treatment is over is whether life insurance is still possible. The honest answer is usually yes, but not immediately, and not at the same price at every insurer. Cancer underwriting in Canada is built around time: time since treatment ended, time without recurrence, and the type and stage of what was treated. Get the timing and the insurer right, and a survivor can often be covered at a price that becomes standard within a few years.

This guide is for survivors who have finished treatment, for people in treatment who want to know what is possible now, and for family members trying to plan. It describes how underwriters assess a cancer history; it is not medical advice.

The three outcomes and what drives them

When an underwriter sees cancer on an application, the decision lands in one of three places:

• Postponed. The most common response soon after diagnosis or treatment. The insurer is not saying no; it is saying “not yet,” and it will usually tell you when to reapply.
• Approved with an extra. Once the waiting period has passed, coverage is offered with either a temporary flat extra (a set dollar amount per $1,000 of coverage per year, for a fixed number of years) or a percentage rating. The extra typically reduces and eventually disappears as recurrence-free years accumulate.
• Standard. Some low-risk cancers qualify at standard rates fairly quickly, and most survivors reach standard or close to it once enough time has passed.

An outright permanent decline is more likely for metastatic or recurrent disease, or for a cancer history combined with other significant health conditions. Even then, no-medical products remain available.

What underwriters look at in life insurance after cancer

Insurers do not treat “cancer” as one thing. The file is assessed on a handful of specifics, and the pathology report is usually the most important document.

Type and site. A basal cell carcinoma, a stage I thyroid cancer and a stage III lung cancer sit at very different points on the risk scale. Underwriting manuals have separate sections for dozens of cancer types.

Stage and grade. Stage describes how far the cancer had spread at diagnosis; grade describes how abnormal the cells looked. Lower stage and lower grade generally mean shorter waiting periods and lighter extras. Lymph node involvement or metastasis lengthens both.

Treatment and its completion date. Underwriters count the waiting period from the end of active treatment, meaning surgery, chemotherapy or radiation, not from diagnosis. Long-term hormone therapy or maintenance medication is usually acceptable during the waiting period, but active treatment generally means a postponement.

Recurrence. A single occurrence followed by clean follow-up is the best case. A recurrence typically restarts the clock and pushes the file into a heavier category.

Follow-up. Regular oncology follow-up with documented clear results is a strong positive. Missed follow-up appointments are a negative, because the underwriter cannot see what the specialist would have seen.

Age and everything else. The same cancer in a 35-year-old and a 65-year-old is assessed differently, and other conditions on the file are weighed alongside it. Smoking history is relevant for several cancers and is rated on its own as well.

Typical waiting periods by cancer category

The table below shows general patterns in Canadian underwriting. Every insurer publishes its own guidelines, they change, and a given case can fall outside these bands. Treat this as orientation, not a rule.

Cancer category	Typical wait after treatment ends	Typical initial offer once eligible
Basal cell or squamous cell skin cancer, fully removed	Often little or none	Standard
Early-stage, low-grade thyroid, prostate, cervical (in situ), some early breast cancers	Roughly 1–3 years	Standard to mild extra
Melanoma (thin, no spread), early bladder, early colon, testicular	Roughly 2–5 years	Temporary flat extra, reducing over time
Most stage II–III solid tumours, lymphomas, leukemias in remission	Roughly 3–7 years	Flat extra or moderate rating, reducing over time
Stage IV, metastatic or recurrent cancers	Often 7–10+ years, some declined	Case by case; no-medical products meanwhile

Two important caveats. First, the bands overlap because the differences between insurers are real: one company might consider an early breast cancer at two years while another waits five. Second, “eligible” does not mean “standard.” The initial offer is often rated, and the improvement comes later.

How a flat extra works, with an illustration

A flat extra is the tool insurers use most for cancer histories because it matches the risk profile: elevated for a few years, then normal. It is quoted as dollars per $1,000 of coverage per year, for a set number of years.

Here is an illustrative example, not a quote. A healthy non-smoking 45-year-old man might pay roughly $48–$70 a month for $500,000 of 20-year term at standard rates. Suppose an insurer offers the same policy to a survivor three years past treatment with a flat extra of $5 per $1,000 for three years:

• Base premium: roughly $48–$70 per month
• Flat extra: $5 × 500 = $2,500 per year, or roughly $208 per month
• Total for the first three years: roughly $256–$278 per month
• From year four onward: the base premium only, roughly $48–$70 per month

A percentage rating works differently. A 200% rating on the same policy would be roughly $96–$140 per month, and unless the insurer agrees to reduce it later, that is the price for the whole term. Which structure is better depends on the numbers and how many years the extra runs; a broker will show you both. Our guide to life insurance underwriting explains ratings in more depth, and rates at age 45 shows what standard pricing looks like.

Coverage while you wait

A postponement can last years, and most people do not want to be uninsured for that long. Several routes keep protection in place:

Convert an existing term policy. If you already own a term policy, it very likely carries a conversion right that lets you switch to permanent coverage without any new medical evidence, usually up to age 65–75. This is exactly the situation that right exists for. Do not let an existing policy lapse while you are in treatment; see how to convert term life to permanent coverage.

Group coverage. Employer group life is typically issued without individual underwriting, at one to two times salary. It ends when you leave the job, but many plans offer a conversion option on departure. Our comparison of group vs. individual life insurance covers the details.

Simplified issue. These policies ask a short list of health questions and require no exam. Many ask whether you have had cancer within a set number of years (often two to five), so a survivor beyond that window may qualify. Amounts are moderate and premiums are higher than fully underwritten coverage. See simplified issue life insurance explained.

Guaranteed issue. No health questions at all, so it is available during treatment. Amounts are small, typically enough for final expenses, and non-accidental death in the first two years usually returns premiums rather than paying the full benefit. It is a floor, not a solution. See guaranteed issue life insurance.

Insure the healthy partner properly. If a spouse has no coverage, or too little, fixing that now protects the household regardless of how your own underwriting goes.

Applying during or immediately after treatment

Applying for fully underwritten coverage during chemotherapy or radiation will almost always produce a postponement, and a postponement sits on your record at that insurer. It is usually better to wait until treatment is complete, gather the pathology and follow-up reports, and then have a broker pre-screen the case anonymously with several insurers before a formal application goes anywhere. That way the only application on file is the one most likely to be approved.

Disclosure, records and the contestability period

Applications ask about any history of cancer, and insurers verify through medical records and the paramedical exam. Leaving it out is not a strategy. A policy can be voided for misrepresentation within the two-year contestability period, and a material omission discovered later can still jeopardize a claim. Full disclosure, submitted to the right insurer, is how survivors get paid claims.

To make the application move quickly, gather:

• the pathology report, with type, stage and grade;
• dates of diagnosis and of the end of each treatment;
• the names of your oncologist and family doctor;
• your most recent follow-up results and the date of your next scan or check-up;
• a list of current medications, including any hormone therapy.

A note on critical illness insurance

Critical illness coverage after cancer is harder than life insurance. Most policies exclude the cancer you had, and some exclude all cancers, or postpone for longer than life insurers do. Coverage for heart attack and stroke may still be available. It is worth asking, and our article on critical illness insurance for cancer explains what the product covers and what survivors can expect.

How Hayes can help

Cancer underwriting is where an independent broker earns their keep. The differences between insurers are larger for cancer than for almost any other condition, and the only way to find the company that will consider you soonest, at the lightest extra, is to ask several. We compare 30+ Canadian insurers, pre-screen your history without putting an application on file, and lay out the flat extra and percentage options side by side. If the answer today is “not yet,” we will tell you when to come back and keep something in place in the meantime. Our advice costs you nothing; the insurers pay us.

Compare quotes from 30+ Canadian insurers in about two minutes, free and with no obligation, or contact us and tell us your history; we will give you a straight read on timing and price. Learn more about the product on our term life insurance page.